For further details see:
GW Pharmaceuticals plc. (GWPH) CEO Justin Gover on 39th Annual JPMorgan Virtual Healthcare Conference - (Transcript)home / stock / gwprf / gwprf news
For further details see:
GW Pharmaceuticals plc. (GWPH) CEO Justin Gover on 39th Annual JPMorgan Virtual Healthcare Conference - (Transcript)Market Wire News is a media platform, the information on this page was provided by SeekingAlpha via Quote Media. Read our full disclaimer.
When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.
Be alerted of any news about your stocks and see what other stocks are trending.
News, Short Squeeze, Breakout and More Instantly...
GWPH stock is moving up double-digits after GW Pharmaceuticals (NASDAQ:GWPH) reported a big jump in its cannabis-derived epilepsy drug, Epidiolex. The medicine uses CBD, and it is known to be an effective treatment for some types of epilepsy. Impressive Quarterly Numbers As everyone k...
CannabisNewsWire Editorial Coverage : As hemp production increases, Californian legislators have extended the duration of thousands of cannabis cultivation licenses to support the state’s thriving industry. Sugarmade Inc. (OTCQB: SGMD) ( SGMD Profile ) is supporting many of these c...
The first passively managed, pure-play exchange-traded fund (ETF) for cannabis investing is now publicly available to investors. On Tuesday (July 9), Innovation Shares’ The Cannabis ETF (ARCA: THCX ) l aunched on NYSE Arca . The THCX focuses on companies in the legal cann...